首页|哌罗匹隆联合奥氮平治疗精神分裂症的疗效及安全性分析

哌罗匹隆联合奥氮平治疗精神分裂症的疗效及安全性分析

扫码查看
目的 探究哌罗匹隆联合奥氮平治疗精神分裂患者的临床疗效.方法 随机选取2021年12月—2023年12月聊城市第四人民医院精神科收治的80例精神分裂症患者为研究对象,根据不同治疗方法分为研究组(n=40)与对照组(n=40).对照组实施奥氮平治疗,研究组在对照组基础上实施哌罗匹隆治疗.对比两组患者的治疗效果、阳性与阴性症状量表评分以及血脂水平.结果 研究组治疗总有效率为95.00%(38/40),高于对照组的80.00%(32/40),差异有统计学意义(χ2=4.114,P=0.042).治疗后,研究组阳性与阴性症状量表评分低于对照组,差异均有统计学意义(P均<0.05).研究组血脂水平优于对照组,差异有统计学意义(P<0.05).结论 哌罗匹隆联合奥氮平治疗精神分裂症的治疗效果较好,可改善患者的精神状况,并可调节血脂代谢.
Analysis of the Efficacy and Safety of Perospirone Combined with Olan-zapine in the Treatment of Schizophrenia
Objective To explore the clinical efficacy of perospirone combined with olanzapine in the treatment of pa-tients with schizophrenia.Methods A total of 80 patients with schizophrenia admitted to the Department of Psychiatry in The Fourth People's Hospital in Liaocheng from December 2021 to December 2023 were randomly selected as the research objects.According to different treatment methods,they were divided into study group(n=40)and control group(n=40).The control group was treated with olanzapine,and the study group was treated with perospirone on the basis of the control group.The therapeutic effect,Positive and Negative Symptom Scale scores and blood lipid levels were compared between the two groups.Results The total effective rate of treatment in the study group was 95.00%(38/40),which was higher than 80.00%(32/40)in the control group,and the difference was statistically significant(χ2=4.114,P=0.042).After treatment,the scores of Positive and Negative Symptom Scale in the study group was lower than that in the control group,and the difference was statistically significant(P<0.05).The blood lipid level of the study group was better than that of the control group,and the difference was statistically significant(P<0.05).Conclu-sion The therapeutic effect of perospirone combined with olanzapine in the treatment of schizophrenia is great,which can improve the mental status of patients and regulate blood lipid metabolism.

PerospironeOlanzapineSchizophreniaTherapeutic effectSecurity

秦海燕、吴红利、王晓蕊、张峰

展开 >

聊城市第四人民医院精神科,山东 聊城 252000

哌罗匹隆 奥氮平 精神分裂症 疗效 安全性

2024

中外医疗
卫生部医院管理研究所 二十一世纪联合创新医药科学研究院

中外医疗

影响因子:0.909
ISSN:1674-0742
年,卷(期):2024.43(33)